MedPath

VINBLASTINE SULFATE INJECTION

VINBLASTINE SULFATE INJECTION

Approved
DIN Number

02183056

Drug Class

Human

Market Date

Apr 14, 1998

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02183056
AIG Number0103625001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CA01 VINBLASTINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

VINBLASTINE SULFATEActive
Strength: 1 MG / ML
Monograph: VINBLASTINE SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.